StreetInsider.com News Articles

Trinity Biotech unit signs cooling fluid deal with data center firm

Wed, 09 Sep 2026 08:31:08 -0400

Trinity Biotech plc (NASDAQ: TRIB) announced that its Trinovium subsidiary has signed a contract with Red Team Investments ("RTI"), a Texas-based modular data center technology company, to supply cooling fluids and analytical systems for AI and high-performance computing data center infrastructure.

Under the agreement, RTI will serve as a commercial pilot customer for Trinovium's direct-to-chip liquid cooling fluids and fluid monitoring systems. The pilot will involve paid product supply and is intended to generate operational performance data to support product validation and broader commercialization.

Trinovium's initial offering is a water-based direct-to-chip cooling formulation built on ultra-high-purity aqueous chemistry and corrosion protection, drawing

Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure

Wed, 09 Sep 2026 08:30:00 -0400

Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure
Data center power densities are increasing rapidly as AI workloads expand, creating greater thermal-management demands and interest in advanced liquid cooling solutions

DUBLIN and WILSONVILLE, Ore., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company, today announced that its Trinovium subsidiary, a dedicated business unit focused on advanced liquid cooling solutions and fluid intelligence systems for next-generation AI data centers,

Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure

Wed, 09 Sep 2026 08:30:00 -0400

Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure
Data center power densities are increasing rapidly as AI workloads expand, creating greater thermal-management demands and interest in advanced liquid cooling solutions

Form 6-K TRINITY BIOTECH PLC For: Aug 28

Fri, 28 Aug 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260828/26999156.html

Form 6-K TRINITY BIOTECH PLC For: Aug 28

Fri, 28 Aug 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260828/26999156.html

Trinity Biotech faces Nasdaq delisting risk over market value

Fri, 28 Aug 2026 17:19:43 -0400

Trinity Biotech plc (NASDAQ: TRIB) received a staff determination letter from Nasdaq on Aug. 28, 2026, notifying the company that it failed to regain compliance with the minimum $15 million market value of publicly held shares requirement by the Aug. 18, 2026 deadline.

The company originally received a deficiency notice from Nasdaq's Listing Qualifications Department on Feb. 19, 2026, and was given 180 calendar days to comply. Having missed that deadline, Trinity Biotech's securities are subject to suspension or delisting unless the company requests a hearing before a Nasdaq Hearings Panel, which it said it intends to do. A hearing request

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

Fri, 28 Aug 2026 17:15:00 -0400

- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress

- PrePsia™ patent portfolio expands to nine granted U.S. and European patents

- Company issues update on Nasdaq listing

DUBLIN, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, today provided an update on key developments across its diagnostics business, highlighting continued commercial progress, operational transformation and diagnostic pipeline advancement.

Strengthening Commercial Leadership in Europe

Trinity Biotech

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

Fri, 28 Aug 2026 17:15:00 -0400

- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress

- PrePsia™ patent portfolio expands to nine granted U.S. and European patents

- Company issues update on Nasdaq listing

Strengthening Commercial Leadership in Europe

Trinity Biotech

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

Fri, 28 Aug 2026 17:15:00 -0400

- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress

- PrePsia™ patent portfolio expands to nine granted U.S. and European patents

- Company issues update on Nasdaq listing

Strengthening Commercial Leadership in Europe

Trinity Biotech

Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update

Fri, 28 Aug 2026 17:15:00 -0400

- Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress

- PrePsia™ patent portfolio expands to nine granted U.S. and European patents

- Company issues update on Nasdaq listing

Strengthening Commercial Leadership in Europe

Trinity Biotech

Form POS AM TRINITY BIOTECH PLC

Fri, 28 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260828/26998251.html

Form POS AM TRINITY BIOTECH PLC

Fri, 28 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260828/26998251.html

Form AW TRINITY BIOTECH PLC

Thu, 27 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260827/26990693.html

Form AW TRINITY BIOTECH PLC

Thu, 27 Aug 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260827/26990693.html

Form F-1/A TRINITY BIOTECH PLC

Fri, 21 Aug 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260821/26960798.html

Form F-1/A TRINITY BIOTECH PLC

Fri, 21 Aug 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260821/26960798.html

Trinity Biotech's Trinovium unit partners with Echelon Data Centres

Mon, 17 Aug 2026 08:32:47 -0400

Trinity Biotech plc (NASDAQ: TRIB) announced that its Trinovium subsidiary has agreed to enter into a strategic collaboration with Echelon Data Centres to develop liquid cooling solutions for AI and high-density computing infrastructure.

Echelon, a hyperscale data center owner and operator, has more than 700 MW of capacity under development and over 1.4 GW of secured capacity across Europe. The collaboration will focus on direct-to-chip cooling fluids, thermal management systems, and modular liquid cooling solutions for AI and high-performance computing deployments.

Trinovium is drawing on Trinity Biotech's experience in precision fluid manufacturing and analytical technologies. The subsidiary has developed an initial direct-to-chip

Form 6-K TRINITY BIOTECH PLC For: Aug 17

Mon, 17 Aug 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260817/26935390.html

Form 6-K TRINITY BIOTECH PLC For: Aug 17

Mon, 17 Aug 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260817/26935390.html

Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure

Mon, 17 Aug 2026 08:30:00 -0400

- Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular data center infrastructure

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033¹

DUBLIN and WILSONVILLE, Ore., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB) today announced that Trinovium, a subsidiary focused on advanced liquid cooling solutions and fluid intelligence systems for next-generation AI data centers, has agreed to enter into a strategic collaboration agreement with

Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure

Mon, 17 Aug 2026 08:30:00 -0400

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033¹

Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure

Mon, 17 Aug 2026 08:30:00 -0400

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033¹

Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure

Mon, 17 Aug 2026 08:30:00 -0400

- Data center liquid cooling market is projected to grow from $4 billion in 2026 to $27 billion by 2033¹

Form 6-K TRINITY BIOTECH PLC For: Aug 14

Fri, 14 Aug 2026 10:09:00 -0400

si-local-file:///var/storage/secattach/20260814/26926151.html

Form 6-K TRINITY BIOTECH PLC For: Aug 14

Fri, 14 Aug 2026 10:09:00 -0400

si-local-file:///var/storage/secattach/20260814/26926151.html